Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis

This study has been terminated.
(Independent steering committee has stopped the trial based on results of a prespecified, blinded interim analysis. It was not stopped due to safety concerns.)
Information provided by:
Walter Reed Army Medical Center Identifier:
First received: November 8, 2006
Last updated: June 16, 2009
Last verified: June 2009